Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality study reveals how age impacts your reach

NCT ID NCT07435506

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how young adults (ages 18-28) and healthy older adults (ages 65-75) perform a simple reaching task in virtual reality. Participants wear a VR headset and use a controller to touch targets of different sizes. The goal is to see if age and added visual feedback change how quickly and accurately people move. Results will help design better VR activities for older adults and people with movement difficulties.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-28 (young adults \[YA\] group) or 65-75 (healthy older adults \[HOA\] group) * Right-handed * Normal or corrected-to-normal vision (glasses or contact lenses permitted) * Clear and comfortable vision through the head-mounted display during a brief fitting (very bulky glasses may be incompatible) * No self-reported history of neurological or psychiatric disorders, as confirmed by participant report and cross-checked against a standardized list of relevant medications * Able to provide informed consent and follow experimental instructions in French or English Additional criteria for HOA * Normal cognitive functioning (Montreal cognitive assessment \[MoCA\] score ≥ 26) * No self-reported acute or chronic pain in the dominant arm, shoulder, or elbow that would preclude performing repetitive arm movements in space. * Self-reported full functional range of motion in the dominant arm (able to extend the arm fully without discomfort or restriction) Exclusion Criteria: * Individuals currently playing video games more than 5 hours/week. * Uncorrected visual, auditory, or motor impairments that would interfere with task performance. * Participant height outside the range of 1.50-1.80 m. * Self-reported diagnosis of a neurodegenerative disease (e.g., Parkinson's disease, Alzheimer's disease) * Self-reported use of medications known to significantly affect cognitive or motor function (a list of relevant medications will be presented during screening). * Cervical pain that could preclude wearing the VR headset during the full duration of the experimental session. * Self-reported history of severe motion sickness or vestibular issues that could be exacerbated by VR exposure * High susceptibility to cybersickness, as assessed via the Visually Induced Motion Sickness Susceptibility Questionnaire which was developed specifically for pre-exposure screening; cut-off: ≥ 12. * Individuals for whom the headset cannot be properly adjusted, e.g., due to an interpupillary distance outside the adjustment range of the head-mounted display (i.e., \<53 mm or \>75 mm).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy older adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculté des Sciences du Sport, Aix Marseille University - Campus Luminy

    Marseille, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.